JPH0475933B2 - - Google Patents
Info
- Publication number
- JPH0475933B2 JPH0475933B2 JP59269131A JP26913184A JPH0475933B2 JP H0475933 B2 JPH0475933 B2 JP H0475933B2 JP 59269131 A JP59269131 A JP 59269131A JP 26913184 A JP26913184 A JP 26913184A JP H0475933 B2 JPH0475933 B2 JP H0475933B2
- Authority
- JP
- Japan
- Prior art keywords
- latex
- antibacterial
- composition
- glycine hydrochloride
- natural rubber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229920000126 latex Polymers 0.000 claims description 38
- 239000004816 latex Substances 0.000 claims description 38
- 239000000203 mixture Substances 0.000 claims description 25
- 239000003242 anti bacterial agent Substances 0.000 claims description 22
- 230000000844 anti-bacterial effect Effects 0.000 claims description 20
- 229920006173 natural rubber latex Polymers 0.000 claims description 11
- 125000002091 cationic group Chemical group 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 229920001059 synthetic polymer Polymers 0.000 claims description 6
- IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 claims description 5
- 229960001269 glycine hydrochloride Drugs 0.000 claims description 5
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- KSJOYCSSVGABBK-UHFFFAOYSA-N 2-[bis(2-aminoethyl)amino]tetradecanoic acid;hydrochloride Chemical compound Cl.CCCCCCCCCCCCC(C(O)=O)N(CCN)CCN KSJOYCSSVGABBK-UHFFFAOYSA-N 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 description 8
- 229920001971 elastomer Polymers 0.000 description 8
- 239000002245 particle Substances 0.000 description 7
- 230000007774 longterm Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000000645 desinfectant Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- UJGGQEYOOLJLOB-UHFFFAOYSA-N 2-[bis[2-(octylamino)ethyl]amino]acetic acid;hydrochloride Chemical compound Cl.CCCCCCCCNCCN(CC(O)=O)CCNCCCCCCCC UJGGQEYOOLJLOB-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000003093 cationic surfactant Substances 0.000 description 3
- 239000000084 colloidal system Substances 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- -1 n is 2 Chemical group 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 230000002459 sustained effect Effects 0.000 description 3
- 230000002485 urinary effect Effects 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- 244000043261 Hevea brasiliensis Species 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001993 dienes Chemical class 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920003052 natural elastomer Polymers 0.000 description 2
- 229920001194 natural rubber Polymers 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- PMJHHCWVYXUKFD-SNAWJCMRSA-N (E)-1,3-pentadiene Chemical compound C\C=C\C=C PMJHHCWVYXUKFD-SNAWJCMRSA-N 0.000 description 1
- PRBHEGAFLDMLAL-UHFFFAOYSA-N 1,5-Hexadiene Natural products CC=CCC=C PRBHEGAFLDMLAL-UHFFFAOYSA-N 0.000 description 1
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 241001156739 Actinobacteria <phylum> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 244000286663 Ficus elastica Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 241001467460 Myxogastria Species 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 1
- 125000004018 acid anhydride group Chemical group 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- YACLQRRMGMJLJV-UHFFFAOYSA-N chloroprene Chemical compound ClC(=C)C=C YACLQRRMGMJLJV-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000004070 electrodeposition Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- GEAWFZNTIFJMHR-UHFFFAOYSA-N hepta-1,6-diene Chemical compound C=CCCCC=C GEAWFZNTIFJMHR-UHFFFAOYSA-N 0.000 description 1
- PYGSKMBEVAICCR-UHFFFAOYSA-N hexa-1,5-diene Chemical compound C=CCCC=C PYGSKMBEVAICCR-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- XMYQHJDBLRZMLW-UHFFFAOYSA-N methanolamine Chemical group NCO XMYQHJDBLRZMLW-UHFFFAOYSA-N 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- PMJHHCWVYXUKFD-UHFFFAOYSA-N piperylene Natural products CC=CC=C PMJHHCWVYXUKFD-UHFFFAOYSA-N 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 201000004537 pyelitis Diseases 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 238000004073 vulcanization Methods 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- DUBNHZYBDBBJHD-UHFFFAOYSA-L ziram Chemical compound [Zn+2].CN(C)C([S-])=S.CN(C)C([S-])=S DUBNHZYBDBBJHD-UHFFFAOYSA-L 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Description
【発明の詳細な説明】
本発明は、抗菌性ラテツクス組成物に関するも
のであり、その目的とするところは接続的な抗菌
活性を有する医療器具、衛生用品、食品製造用機
器又は備品等のラテツクス成型品を製造するに好
適な抗菌性ラテツクス組成物を提供するところに
ある。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an antibacterial latex composition, and its purpose is to mold latex for medical devices, sanitary products, food manufacturing equipment, supplies, etc., which have a positive antibacterial activity. An object of the present invention is to provide an antibacterial latex composition suitable for manufacturing products.
従来から医療、衛生検査あるいは食品分野にお
いては、種々雑多な細菌、放射菌、真菌、粘菌あ
るいはウイルス等からの汚染や感染を防止するた
めに、種々の殺菌消毒剤が用いられている。なか
でも両性型抗菌剤は、広い範囲の微生物に強力な
殺菌力を有し、かつ人体に対する毒性も低いとこ
ろから、今日、数ある抗菌剤の中でも最も広く使
用されている殺菌消毒剤の一つである。現在、こ
れらは通常、水溶液として提供されるため、医療
器具等は使用に先立ちこの水溶液に浸漬するか又
はこの水溶液を噴霧することにより一応、所期の
目的は達せられている。 Conventionally, various sterilizing disinfectants have been used in the medical, sanitary inspection, and food fields to prevent contamination and infection from various types of bacteria, actinobacteria, fungi, slime molds, viruses, and the like. Among these, amphoteric antibacterial agents are one of the most widely used sterilizing disinfectants among the many antibacterial agents available today, as they have strong sterilizing power against a wide range of microorganisms and have low toxicity to the human body. It is. Currently, these are usually provided as aqueous solutions, and the intended purpose can be achieved by immersing medical instruments in the aqueous solution or spraying the aqueous solution before use.
しかし、医療器具等を長期間にわたり使用する
場合には初期の消毒のみでは抗菌剤としての効力
が次第に低下ないし消失することは、我々が日常
しばしば経験するところでありその改善が強く望
まれている。 However, when medical instruments are used for a long period of time, we often experience in our daily lives that the effectiveness of antibacterial agents gradually decreases or disappears if only the initial disinfection is performed, and there is a strong desire to improve this situation.
その最も有効な対策としてその使用過程におい
て、上記器具中より最小(発育)阻止濃度以上の
抗菌剤が一定量ずつ除放されるシステムが考えら
れる。このようなシステムの実現のためには、抗
菌剤が均一かつ安定に分散したラテツクスを得、
このものを、例えば医療器具等に成型することが
必要であるが、両性型抗菌剤が均一かつ安定に分
散したラテツクスは、以下に述べるように、これ
までに得られていない。 The most effective countermeasure would be a system in which a fixed amount of antibacterial agent at a minimum (growth) inhibitory concentration or higher is released from the device during the course of its use. In order to realize such a system, it is necessary to obtain latex in which antibacterial agents are uniformly and stably dispersed.
Although it is necessary to mold this material into, for example, medical instruments, a latex in which an amphoteric antibacterial agent is uniformly and stably dispersed has not been obtained so far, as described below.
まず、疎水性の天然ゴム又は合成高分子化合物
を水媒体中に分散させた高分子ラテツクスは、今
日、種々の有用な用途に用いられているが、通
常、これらラテツクス中にはラテツクス粒子の安
定な浮遊分散を助けるために各種界面活性剤や保
護コロイド等が含まれている。例えば天然ゴムラ
テツクスにおいては、その成分中に含まれる両性
電解質であるタンパク質がゴム粒子の表面に吸着
することにより一種の保護コロイド的な役割を果
たし、ラテツクス粒子の安定な分散を助けてい
る。また、天然ゴムラテツクスは、その中に含ま
れている酵素や細菌の作用で酸を生じて凝固しや
すいので、通常、これを防ぐため0.3〜1.0%のア
ンモニアが添加され、液はアルカリ性を保つてい
る。従つてゴム粒子は基本的には負に帯電するこ
とにより、粒子間相互の静電気的な反撥力により
凝集することなく安定に浮遊分散していることに
なる。また、合成高分子系ラテツクスにおいても
重合前又は重合後にアニオン系あるいは/及びノ
ニオン系界面活性剤が添加されており、実用的に
は特別な事情がない限りカチオン系界面活性剤が
用いられている例は極めて少ない。したがつて、
従来これらラテツクス溶液に両性型抗菌剤を加え
るとラテツクス溶液はコロイド的に不安定化され
る結果、ラテツクス粒子は遅かれ速かれ凝集ない
しゲル化を起こし、長期の保存安定性に優れた抗
菌性ラテツクス組成物を得ることはできなかつ
た。 First, polymer latexes in which hydrophobic natural rubber or synthetic polymer compounds are dispersed in an aqueous medium are used for a variety of useful purposes today, but these latexes usually contain a substance that stabilizes the latex particles. Contains various surfactants and protective colloids to aid in floating and dispersion. For example, in natural rubber latex, protein, which is an ampholyte contained in its components, is adsorbed onto the surface of rubber particles, thereby acting as a kind of protective colloid and helping to stabilize the dispersion of latex particles. In addition, natural rubber latex tends to generate acid and coagulate due to the action of enzymes and bacteria contained in it, so to prevent this, 0.3 to 1.0% ammonia is usually added to keep the liquid alkaline. There is. Therefore, since the rubber particles are basically negatively charged, they are stably suspended and dispersed without agglomeration due to the mutual electrostatic repulsion between the particles. Also, anionic and/or nonionic surfactants are added to synthetic polymer latexes before or after polymerization, and cationic surfactants are used in practice unless there are special circumstances. There are very few examples. Therefore,
Conventionally, when an amphoteric antibacterial agent is added to these latex solutions, the latex solution becomes colloidally unstable, and as a result, the latex particles sooner or later agglomerate or gel, resulting in an antibacterial latex composition with excellent long-term storage stability. I couldn't get anything.
本発明者らは、持続的な抗菌活性を有するラテ
ツクスから成る医療器具、衛生用品、食品製造用
備品等を製造するに好適な抗菌性ラテツクス組成
物、とりわけ長期保存安定性に優れた抗菌性ラテ
ツクス組成物を提供することを目的として鋭意検
討を進めた結果、驚くべきことにカチオン系天然
ゴムラテツクス又はカチオン系合成高分子ラテツ
クスと特定の両性型抗菌剤とを配合することによ
り所期の目的が達成されることを見い出し、本発
明に到達したものである。 The present inventors have developed an antibacterial latex composition suitable for manufacturing medical equipment, sanitary goods, food manufacturing equipment, etc. made of latex having sustained antibacterial activity, and in particular an antibacterial latex composition with excellent long-term storage stability. As a result of intensive research aimed at providing a composition, surprisingly, the desired purpose was achieved by blending cationic natural rubber latex or cationic synthetic polymer latex with a specific amphoteric antibacterial agent. This is what led to the discovery of the present invention.
すなわち本発明は、カチオン系天然ゴムラテツ
クス又はカチオン系合成高分子ラテツクスと、下
記一般式()で示される両性型抗菌剤とを配合
してなる抗菌性ラテツクス組成物である。 That is, the present invention is an antibacterial latex composition comprising a cationic natural rubber latex or a cationic synthetic polymer latex and an amphoteric antibacterial agent represented by the following general formula ().
〔式中、R1はR(NHCH2CH2)o、R2は
RNHCH2CH2又は水素原子を表し、Rは炭素数
8〜18のアルキル基を表し、nは1〜3の整数で
ある。〕
本発明に用いられる両性型抗菌剤は、前記一般
式()で示されるアルキルポリアミノエチルグ
リシン塩酸塩である。一般式()におけるRの
炭素数が8未満であるか18をこえる場合、又はn
が4以上の場合には、得られる組成物の抗菌力が
低いので適当でない。一般式()で示されるア
ルキルポリアミノエチルグリシン塩酸塩の好まし
い具体例としては、R1のRの炭素数が12、nが
2、R2がHであるドデシルジ(アミノエチル)
グリシン塩酸塩、R1のRの炭素数が14、nが2、
R2がHであるテトラデシルジ(アミノエチル)
グリシン塩酸塩、R1のRの炭素数が8、nが1、
R2のRの炭素数が8であるジ(オクチルアミノ
エチル)グリシン塩酸塩があげられる。本発明に
おいて両性型抗菌剤は単独で用いることもできる
し、また2種以上を併用することもできる。 [In the formula, R 1 is R(NHCH 2 CH 2 ) o , R 2 is
RNHCH 2 CH 2 or a hydrogen atom, R represents an alkyl group having 8 to 18 carbon atoms, and n is an integer of 1 to 3. ] The amphoteric antibacterial agent used in the present invention is alkylpolyaminoethylglycine hydrochloride represented by the above general formula (). When the number of carbon atoms in R in the general formula () is less than 8 or exceeds 18, or n
is 4 or more, it is not suitable because the antibacterial activity of the resulting composition is low. Preferred specific examples of the alkyl polyaminoethylglycine hydrochloride represented by the general formula () include dodecyl di(aminoethyl) in which R 1 has 12 carbon atoms, n is 2, and R 2 is H;
Glycine hydrochloride, R in R 1 has 14 carbon atoms, n is 2,
Tetradecyl di(aminoethyl) where R 2 is H
Glycine hydrochloride, R in R 1 has 8 carbon atoms, n is 1,
Examples include di(octylaminoethyl)glycine hydrochloride in which R in R 2 has 8 carbon atoms. In the present invention, amphoteric antibacterial agents can be used alone or in combination of two or more.
本発明の抗菌性ラテツクス組成物における両性
型抗菌剤の含有量は、その目的とするところによ
り異なるが、通常、ラテツクスの固形分に対して
好ましくは0.01〜30wt%、より好ましくは0.1〜
10wt%である。含有量が30wt%をこえる場合は
このラテツクス組成物より得られた成型品の皮膜
の物理的強度が劣る傾向があり、一方、0.01wt%
未満では抗菌剤としての効力を発揮しにくくなる
ので好ましくない。 The content of the amphoteric antibacterial agent in the antibacterial latex composition of the present invention varies depending on the purpose, but is usually preferably 0.01 to 30 wt%, more preferably 0.1 to 30 wt%, based on the solid content of the latex.
It is 10wt%. If the content exceeds 30wt%, the physical strength of the film of the molded product obtained from this latex composition tends to be poor;
If it is less than that, it becomes difficult to exert its effectiveness as an antibacterial agent, which is not preferable.
天然ゴムラテツクスとは、ゴム植物の樹皮に切
付を行つた時に流れ出る種々の有機物及び無機物
を含有した水溶液を分散媒体とし、ゴム分を分散
質とし、必要に応じてPH調整剤、加硫剤、加硫促
進剤、軟化剤、充填剤、老化防止剤、着色剤等を
配合したラテツクスを加硫したものであり、通常
のラテツクスはPH調整剤としてのアンモニアを
0.3〜1.0wt%含み、PHが9〜11に調整されたアニ
オン系ラテツクスである。これに対し本発明に用
いられるカチオン系天然ゴムラテツクスとして
は、PHが保護コロイドであるタンパク質の等電点
であるPH4.7以上、好ましくは3以下のいわゆる
酸性ラテツクスがあげられ、このものは、その状
態ではゴム粒子は通常の天然ゴムラテツクスとは
逆の正電荷を帯びて互いに反撥することにより安
定化している。このような酸性ラテツクスは、た
とえば通常の天然ゴムラテツクス(固形分濃度50
〜60%、PH=9〜11)に対し、カチオン系界面活
性剤又はノニオン系界面活性剤をゴム分に対して
1〜5wt%程度になるように加え、次に適当な無
機酸又は有機酸を加えてPHを4.7以下、好ましく
は3以下にすればよい。このような酸性ラテツク
スは、従来特殊な例として負電荷をもつ繊維や紙
類の処理の場合又はラテツクスから直接塩酸ゴ
ム、塩化ゴム又は還元ゴムのような誘導体をつく
る時以外はほとんど用いられておらず、本発明の
ように両性型抗菌剤を配合した例については従来
全く知られていない。 Natural rubber latex is made by using an aqueous solution containing various organic and inorganic substances that flows out when cutting is made on the bark of a rubber plant as a dispersion medium, and using the rubber component as a dispersoid. It is a vulcanized latex containing vulcanization accelerators, softeners, fillers, anti-aging agents, colorants, etc. Ordinary latex contains ammonia as a PH regulator.
It is an anionic latex containing 0.3 to 1.0 wt% and having a pH adjusted to 9 to 11. On the other hand, the cationic natural rubber latex used in the present invention includes a so-called acidic latex whose pH is 4.7 or higher, and preferably 3 or lower, which is the isoelectric point of the protein that is the protective colloid. In this state, the rubber particles are stabilized by having a positive charge opposite to that of normal natural rubber latex and repelling each other. Such acidic latex is, for example, ordinary natural rubber latex (solid content concentration 50
~60%, PH=9~11), add a cationic surfactant or nonionic surfactant to about 1~5wt% based on the rubber content, and then add a suitable inorganic or organic acid. may be added to bring the pH to 4.7 or less, preferably 3 or less. Such acid latexes have rarely been used in the past, except as special cases in the treatment of negatively charged fibers and papers, or in the production of derivatives such as hydrochloric acid rubber, chlorinated rubber, or reduced rubber directly from the latex. First, there has been no known example of incorporating an amphoteric antibacterial agent as in the present invention.
またカチオン系合成高分子系ラテツクスとして
は、例えばエチレン、スチレン、酢酸ビニル、塩
化ビニル、塩化ビニリデン、アクリロニトリル、
(メタ)アクリル酸エステル、ビニルピリジン、
メチルビニルエーテル等のビニル系モノマーの単
一重合体又はその共重合体、ブタジエン、イソプ
レン、1,3−ペンタジエン、1,5−ヘキサジ
エン、1,6−ヘプタジエン、クロロプレン等の
ジエン系モノマーの単一重合体あるいはその共重
合体、上記ビニル系モノマーとジエン系モノマー
の共重合体、その他官能基としてエポキシド基、
アミノ基、カルボキシル基、酸無水物基、水酸
基、アミド基、N−メチロールアミド基、イソシ
アネート基等を有するビニル系モノマーと上記各
種モノマーとの共重合体等を主成分とし、これに
乳化分散剤としてカチオン型界面活性剤を配合し
たものがあげられ、必要に応じてノニオン系界面
活性剤、架橋剤、充填剤、軟化剤等を配合したも
のであつてもよい。 Examples of cationic synthetic polymer latexes include ethylene, styrene, vinyl acetate, vinyl chloride, vinylidene chloride, acrylonitrile,
(meth)acrylic acid ester, vinylpyridine,
Homopolymers of vinyl monomers such as methyl vinyl ether or copolymers thereof, homopolymers of diene monomers such as butadiene, isoprene, 1,3-pentadiene, 1,5-hexadiene, 1,6-heptadiene, chloroprene, etc. The copolymer, a copolymer of the above-mentioned vinyl monomer and diene monomer, and an epoxide group as a functional group,
The main component is a copolymer of a vinyl monomer having an amino group, a carboxyl group, an acid anhydride group, a hydroxyl group, an amide group, an N-methylolamide group, an isocyanate group, etc. and the above various monomers, and an emulsifying dispersant is added to the copolymer. Examples include those containing a cationic surfactant, and may also contain a nonionic surfactant, a crosslinking agent, a filler, a softener, etc., if necessary.
本発明の抗菌性ラテツクス組成物を調整する方
法は、各成分が均一に混合される方法であれば特
に限定されず、公知の種々の方法を利用すること
ができる。例えば易水溶性の殺菌剤の場合には、
その水溶液を直接ラテツクス中に添加すればよい
し、また難水溶性の殺菌剤であつて固形状のもの
である場合にはボールミル内で摩砕しながら均一
なペースト状水分散物とし、これをラテツクス中
に加えて撹拌混合するなどの方法が好ましく採用
される。 The method for preparing the antibacterial latex composition of the present invention is not particularly limited as long as each component is mixed uniformly, and various known methods can be used. For example, in the case of easily water-soluble disinfectants,
The aqueous solution can be directly added to the latex, or if the disinfectant is a solid that is poorly water-soluble, it can be ground in a ball mill to form a uniform paste-like aqueous dispersion. A method such as adding it to latex and stirring and mixing it is preferably employed.
本発明の抗菌性ラテツクス組成物は、長期の使
用過程においても持続的な抗菌性を有する医療器
具、衛生器具、食品製造用機器又は備品等の成型
加工に好適に用いられる。具体的な成型品の例と
しては、導尿カテーテルをはじめとする各種カテ
ーテル類、採尿バツグ等のバツグ類、給排液チユ
ーブ、スポンジ、ゴム引布、紙のサイジング剤、
不織布のバインダー、塗料、接着剤等があげられ
る。これらは従来公知の浸漬法、キヤステイング
法又は電着法等により成型される。さらに具体的
な応用例をあげるならば長期間における体内留置
においてカテーテルを通じて侵入する細菌により
尿道炎、膀胱炎、腎う炎等が頻発する導尿カテー
テルについて、本発明の抗菌性ラテツクス組成物
を用いて成型された導尿カテーテルは抗菌剤を徐
放する性能を有し、その使用過程において尿又は
体液により抗菌剤が持続的に徐放されるので、
種々の細菌からの尿路感染を防止する上で極めて
効果的である。 The antibacterial latex composition of the present invention can be suitably used for molding medical instruments, sanitary instruments, food manufacturing equipment or fixtures, etc., which have sustained antibacterial properties even during long-term use. Examples of specific molded products include various catheters including urinary catheters, bags such as urine collection bags, fluid supply and drainage tubes, sponges, rubberized cloth, paper sizing agents,
Examples include non-woven fabric binders, paints, adhesives, etc. These are molded by a conventionally known dipping method, casting method, electrodeposition method, or the like. To give a more specific application example, the antibacterial latex composition of the present invention can be used for urinary catheters, which frequently cause urethritis, cystitis, pyelitis, etc. due to bacteria that invade through the catheter when left in the body for a long period of time. The urinary catheter molded in this way has the ability to release antibacterial agents in a sustained manner, and during its use, the antibacterial agents are continuously released in urine or body fluids.
It is extremely effective in preventing urinary tract infections from various bacteria.
以下に具体的な実施例を記し本発明を詳述す
る。 The present invention will be described in detail with reference to specific examples below.
なお、例中の「部」は「重量部」を意味する。 Note that "parts" in the examples mean "parts by weight."
実施例 1
固形分濃度が約50wt%の酸性天然ゴムラテツ
クス溶液(PH2.5)100部に、ジメチルジチオカル
バミン酸亜鉛0.3部、硫黄1.3部、亜鉛華2.8部及び
ステアリン酸1.2部を加え、均一に分散させて天
然ゴムを主成分とする配合ラテツクスを得た。こ
の配合ラテツクスに、抗菌剤としてドデシルジ
(アミノエチル)グリシン塩酸塩20%水溶液10部
を加えたところ、ラテツクスは凝集することな
く、抗菌剤が均一に分散したラテツクス組成物を
得ることができた。このラテツクス組成物は3カ
月間放置後においてもゲル化することなく安定で
あつた。得られた組成物からはフイルムを成型す
ることができ、このフイルムについてBacillus
Subtilis ATCC 6633(培地 NUTRIENT
AGAR)を検定菌としてせん孔平板法により抗
菌活性テストを行つたところ阻止円を生じ、この
組成物が抗菌性を有することが認められた。Example 1 0.3 parts of zinc dimethyldithiocarbamate, 1.3 parts of sulfur, 2.8 parts of zinc white, and 1.2 parts of stearic acid were added to 100 parts of acidic natural rubber latex solution (PH2.5) with a solid content concentration of approximately 50 wt%, and uniformly dispersed. A compounded latex containing natural rubber as the main component was obtained. When 10 parts of a 20% aqueous solution of dodecyldi(aminoethyl)glycine hydrochloride as an antibacterial agent was added to this compounded latex, the latex did not aggregate and a latex composition in which the antibacterial agent was uniformly dispersed could be obtained. This latex composition remained stable without gelation even after being left for 3 months. A film can be formed from the obtained composition, and about this film, Bacillus
Subtilis ATCC 6633 (medium NUTRIENT
When an antibacterial activity test was conducted using the punch plate method using A.GAR) as a test bacterium, an inhibition zone was observed, indicating that this composition had antibacterial properties.
比較例 1
実施例1と同じ組成のアルカリ性(PH9.8)天
然ゴムラテツクスに実施例1に用いたのと同じ抗
菌剤を加えたところ、直ちにゲル化した。Comparative Example 1 When the same antibacterial agent used in Example 1 was added to an alkaline (PH9.8) natural rubber latex having the same composition as in Example 1, it immediately gelled.
実施例 2
殺菌剤としてテトラデシルジ(アミノエチル)
グリシン塩酸塩の10%水溶液を用いた以外は実施
例1と同じ実験を行つたところ、実施例1と同様
に3カ月以上の長期の保存安定性の良好な組成物
が得られ、またそのものから成形されたフイルム
が抗菌活性を有することも確認された。Example 2 Tetradecyl di(aminoethyl) as a fungicide
When the same experiment as in Example 1 was conducted except that a 10% aqueous solution of glycine hydrochloride was used, a composition with good long-term storage stability for 3 months or more was obtained as in Example 1, and It was also confirmed that the formed film had antibacterial activity.
実施例 3
抗菌剤としてジ(オクチルアミノエチル)グリ
シン塩酸塩の10%水溶液を用いた以外は実施例1
と同じ実験を行つたところ、実施例1と同様に3
カ月以上の長期の保存安定性の優れた組成物が得
られ、またそのものから成形されたフイルムが抗
菌性を有することも確認された。Example 3 Example 1 except that a 10% aqueous solution of di(octylaminoethyl)glycine hydrochloride was used as the antibacterial agent.
When the same experiment was conducted as in Example 1, 3
A composition with excellent long-term storage stability for more than a month was obtained, and it was also confirmed that a film formed from the composition had antibacterial properties.
実施例 4,5
ジ(オクチルアミノエチル)グリシン塩酸塩に
かえてオクタデシルジ(アミノエチル)グリシン
塩酸塩又はドデシルトリ(アミノエチル)グリシ
ン塩酸塩を用いた以外は実施例4と同様にして実
験を行つたところ、実施例4と同様に3カ月以上
の長期の保存安定性の優れた組成物が得られ、ま
たそのものから成形されたフイルムが抗菌性を有
することも確認された。Examples 4 and 5 Experiments were carried out in the same manner as in Example 4, except that octadecyldi(aminoethyl)glycine hydrochloride or dodecyltri(aminoethyl)glycine hydrochloride was used instead of di(octylaminoethyl)glycine hydrochloride. As a result, as in Example 4, a composition with excellent long-term storage stability of 3 months or more was obtained, and it was also confirmed that a film formed from the composition had antibacterial properties.
Claims (1)
系合成高分子ラテツクスと、下記一般式()で
示される両性型抗菌剤とを配合してなる抗菌性ラ
テツクス組成物。 〔式中、R1はR(NHCH2CH2)o、R2は
RNHCH2CH2又は水素原子を表し、Rは炭素数
8〜18のアルキル基を表し、nは1〜3の整数で
ある。〕 2 両性抗菌剤がドデシルジ(アミノエチル)グ
リシン塩酸塩、テトラデシルジ(アミノエチル)
グリシン塩酸塩又はジ(オクチルアミノエチル)
グリシン塩酸塩である特許請求の範囲第1項記載
の組成物。[Scope of Claims] 1. An antibacterial latex composition comprising a cationic natural rubber latex or a cationic synthetic polymer latex and an amphoteric antibacterial agent represented by the following general formula (). [In the formula, R 1 is R(NHCH 2 CH 2 ) o , R 2 is
RNHCH 2 CH 2 or a hydrogen atom, R represents an alkyl group having 8 to 18 carbon atoms, and n is an integer of 1 to 3. ] 2 Amphoteric antibacterial agents are dodecyl di(aminoethyl)glycine hydrochloride and tetradecyl di(aminoethyl)
Glycine hydrochloride or di(octylaminoethyl)
The composition according to claim 1, which is glycine hydrochloride.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59269131A JPS61145235A (en) | 1984-12-19 | 1984-12-19 | Antibacterial latex composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59269131A JPS61145235A (en) | 1984-12-19 | 1984-12-19 | Antibacterial latex composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61145235A JPS61145235A (en) | 1986-07-02 |
| JPH0475933B2 true JPH0475933B2 (en) | 1992-12-02 |
Family
ID=17468121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59269131A Granted JPS61145235A (en) | 1984-12-19 | 1984-12-19 | Antibacterial latex composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61145235A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20130134348A (en) * | 2012-05-30 | 2013-12-10 | 삼성전자주식회사 | Air conditional and method for controlling the same |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02234762A (en) * | 1989-03-08 | 1990-09-17 | Unitika Ltd | Medical adhesive tape or sheet |
| JP5100027B2 (en) * | 2006-04-20 | 2012-12-19 | 株式会社ブリヂストン | Method for producing enzyme-treated natural rubber latex, natural rubber and rubber composition thereof |
-
1984
- 1984-12-19 JP JP59269131A patent/JPS61145235A/en active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20130134348A (en) * | 2012-05-30 | 2013-12-10 | 삼성전자주식회사 | Air conditional and method for controlling the same |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61145235A (en) | 1986-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0516184B1 (en) | Antimicrobial latex composition | |
| EP0141628B1 (en) | Antimicrobial latex composition shaped article produced therefrom, and method of manufacturing a shaped article | |
| CN101432353B (en) | Antiseptic-containing silicone elastomers | |
| JPH05230325A (en) | Antibacterial, antifungal polyacetal resin composition | |
| JPH0733321B2 (en) | Antibacterial silica gel and antibacterial resin | |
| JPH0425301B2 (en) | ||
| CN114246180A (en) | Foam cleaning disinfectant and preparation method thereof | |
| JPH0580225B2 (en) | ||
| JPH0475933B2 (en) | ||
| Rojruthai et al. | The use of 1, 2-benzisothiazolin-3-one (BIT) in preparation of low-ammonia and zinc-free natural rubber latex concentrate | |
| JP3589842B2 (en) | Molding method from mixture of pre-vulcanized natural rubber latex and water-soluble polymer and molded article thereof | |
| JPS6094460A (en) | Antimicrobial latex composition | |
| JPH0376343B2 (en) | ||
| GB2555955A (en) | Antimicrobial rubber and processes for making the same | |
| CN105385056A (en) | Biological bactericidal plastic | |
| JPH0588900B2 (en) | ||
| JP6615655B2 (en) | Nipple pack material for livestock and method for preventing mastitis of dairy livestock | |
| AU2018312434A1 (en) | Polymerizable compounds with one or more surfactant-like properties | |
| JPH01138246A (en) | Antibacterial latex composition | |
| CN114644763B (en) | Pickering emulsion of amphiphilic thermogel embedded clove oil and preparation method thereof | |
| CN113578016B (en) | Preparation method of micro-nano zinc deodorant for pig farm | |
| JP4117421B2 (en) | Method for preventing microbial growth of sewage treated water and water-soluble composition | |
| JPH0434414B2 (en) | ||
| Yazdi et al. | One pot synthesis of PMMA/silver nanoparticles and its antibacterial properties | |
| JPH0310342B2 (en) |